Amarin Corp Plc (AMRN)

[concapk]

Canes,
You are right to some extent:

Amarin received approval for the Marine indication in 2012 ..... at the end of 2012 in December they entered a deal for $ 100 mil. from Pharmakon to support the commercial launch of Vascepa with the FDA SPA and Anchor indication approval geared to Reduce-It having 50% patient levels.

JZ had trouble with the FDA prior and after the 2013 FDA Commercial Committee Meeting and was blamed for the failure ( conjecture ). He stepped down and handed off the reins to JT. Yes JZ handled the Pharmakon loan during his tenure and probably dealt with early dealings with the Baker Bros. Amarins cash on hand yr. ending 2012 was $276 mil and at end of 2013 was $216 mil, but loans outstanding exceeded $100 MIL. JT the accountant guided Amarin forward.

JZ was not stunned when the FDA reneged on SPA/Anchor ..... the Commercial Committee Meetings approval vote ( 9-2 against ) in 2013 and meetings with the FDA set the stage for JZ stepping down. JZ was very loud and demanding with the FDA.

I believe you are confusing what I was stating that JT was decimated by Judge Du 's ruling.... was lost for a period and handed down the reins to KM.